Moreover, we differentially analyzed CD4+ and CD8+ T cells, as the two main T-cell subsets differentially recognize antigens via HLA-class II or class I molecules, and exert definite effector functions in the immunological tumor control (25). The gene discussed is CD8A; the disease is neoplasm.